Tissue Immunogenicity: The Role of MHC Antigen and the Lymphocyte Costimulator B7-1

Journal of Immunology

Volumn 157, Issue 11, 1996, Pages 4790-4795

  Coulombe, Marilyne ^a   Yang, Huan ^a   Guerder, Sylvie ^b   Flavell, Richard A ^b   Lafferty, Kevin J ^c   Gill, Ronald G ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; HISTOCOMPATIBILITY ANTIGEN;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; METABOLISM; MOUSE; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD80; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030470629     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Lafferty, K. L., and A. J., Cunningham. 1975. A new analysis of allogeneic interactions. Aust. J. Exp. Biol. Med. Sci. 53:27.
2. Lafferty, K. J., S. J. Prowse, and C. J. Simeonovic. 1983. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu. Rev. Immunol. 1:143.
3. Lafferty, K., A. Bootes, G. Dart, and D. Talmage. 1976. Effect of organ culture on the survival of thyroid allografts in mice. Transplantation 22:138.
4. Lacy, P., J. Davie, and E. Finke. 1979. Prolongation of islet allograft survival following in vitro culture (24°C) and a single injection of ALS. Science 204:312.
5. Bowen, K., S. Prowse, and K. Lafferty. 1981. Reversal of diabetes by islet transplantation: vulnerability of the established allograft. Science 213:1261.
6. Faustman, D., V. Hauptfeld, P. Lacy, and J. Davie. 1981. Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc. Natl. Acad. Sci. USA 78:5156.
7. Faustman, D., R. Steinman, H. Gebel, V. Hauptfeld, J. Davie, and P. Lacy. 1984. Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc. Natl. Acad. Sci. USA 81:3684.
8. Hegre, O., G. Hickey, S. Marshall, and J. Serie. 1984. Modification of allograft immunogenicity in perinatal islets isolated and purified in vitro. Transplantation 37:227.
9. La Rosa, F. 1988. Abrogation of mouse pancreatic islet allograft rejection by a four-day culture. Transplantation 46:330.
10. Lau, H., K. Reemtsma, and M. Hardy. 1984. Prolongation of rat islet allograft survival by direct ultraviolet irradiation of the graft. Science 223:607.
11. Hullett, D. A., A. S. Landry, D. K. Leonard, and H. W. Sollinger. 1989. Enhancement of thyroid allograft survival following organ culture. Transplantation 47:24.
12. Markmann, J. F., J. D. Jacobson, H. Kiumura, M. A. Choti, W. F. Hickey, I. J. Fox, W. K. Silvers, C. F. Barker, and A. Naji. 1989. Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts. Transplantation 48:478.
13. La Rosa, F. G., and D. W. Talmage. 1990. Major histocompatibility complex antigen expression on parenchymal cells of thyroid allografts is not by itself sufficient to induce rejection. Transplantation 49:605.
14. Markmann, J. F., H. Bassiri, N. M. Desai, J. S. Odorico, J. I. Kim, B. H. Koller, O. Smithies, and C. F. Barker. 1992. Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. Transplantation 54:1085.
15. Osorio, R. W., N. L. Ascher, R. Jaenisch, C. E. Freise, J. P. Roberts, and P. G. Stock. 1993. Major histocompatibility complex class I deficiency prolongs islet allograft survival. Diabetes 42:1520.
16. Guerder, S., D. E. Picarella, P. S. Linsley, and R. A. Flavell. 1994. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor α leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91:5138.
17. Prowse, S. J., C. J. Simeonovic, K. J. Lafferty, B. C. Bond, C. E. Magi, and D. Mackie. 1984. Allogeneic islet transplantation without recipient immunosuppression. Methods Diabetes Res. 1:253.
18. Gotoh, M., T. Maki, T. Kiyoizumi, S. Satomi, and A. P. Monaco. 1985. An improved method for isolation of mouse pancreatic islets. Transplantation 40:437.
19. Scharp, D. W., C. B. Kemp, M. J. Knight, W. F. Ballinger, and P. E. Lacy. 1973. The use of ficoll in the preparation of viable islets of Langerhans from the rat pancreas. Transplantation 16:686.
20. Parr, E., K. Bowen, and K. Lafferty. 1980. Cellular changes in cultured mouse thyroid glands and islets of Langerhans. Transplantation 30:135.
21. Haskins, K., M. Portas, B. Bradley, D. Wegmann, and K. Lafferty. 1988.T lymphocyte clone specific for pancreatic islet antigen. Diabetes 37:1444.
22. Vesole, D., G. Dart, and D. Talmage. 1982. Rejection of stable cultured allografts by active or passive (adoptive) immunization. Proc. Natl. Acad. Sci. USA 79:1626.
23. Coulombe, M., and R. G. Gill. 1994. Tolerance induction to cultured islet allografts. I. Characterization of the tolerant state. Transplantation 57:1195.
24. + T cells. J. Exp. Med. 173:759.
25. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065.
26. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
27. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1791.
28. Chen, L., P. S. Linsley, and K. E. Hellstrom. 1993. Costimulation of T cells for tumor immunity. Immunol. Today 14:483.
29. + T cells by B7-transfected melanoma cells. Science 259:368.
30. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
31. Harlan, D. M., H. Hengartner, M. L. Huang, Y.-H. Kang, R. Abe, R. W. Moreadith, H. Pircher, G. S. Gray, P. S. Ohashi, G. J. Freeman, L. M. Nadler, C. H. June, and P. Aichele. 1994. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc. Natl. Acad. Sci. USA 91:3137.
32. Guerder, S., J. Meyerhoff, and R. Flavell. 1994. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1:155.
33. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789.
34. Turka, L. A., P. S. Linsley, H. Lin, W. Brady, J. M. Leiden, R. Wei, M. L. Gibson, X. Zheng, S. Myrdal, D. Gordon, T. Bailey, S. F. Bolling, and C. B. Thompson. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 89:11102.
35. Pearson, T. C., D. Z. Alexander, K. J. Winn, P. S. Linsley, R. P. Lowry, and C. P. Larsen. 1994. Transplantation tolerance induced by CTLA4-Ig. Transplantation 57:1701.
36. Chahine, A. A., M. Yu, M. M. McKernan, C. Stoeckert, and H. T. Lau. 1995. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells. Transplantation 59:1313.
37. Sayegh, M. H., E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, P. S. Linsley, and L. A. Turka. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181:1869.
38. Markmann, J., D. Lo, A. Naji, R. D. Palmiter, R. L. Brinster, and E. Heber-Katz. 1988. Antigen presenting function of class II MHC expressing pancreatic beta cells. Nature 336:476.
39. Wood, K. J., A. Hopley, M. J. Dallman, and P. J. Morris. 1988. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection. Transplantation 45:759.
40. Wright, J. R., V. Hauptfeld, and P. E. Lacy. 1989. Induction of Ia antigen expression on murine islet parenchymal cells does not diminish islet allograft survival. Am. J. Pathol. 134:237.
41. Kneteman, N. M., P. F. Halloran, W. D. Sanden, T. Wang, and R. E. A. Seelis. 1991. Major histocompatibility complex antigens and murine islet allograft survival. Transplantation 51:247.
42. Stock, P. G., N. L. Ascher, S. Chen, J. Field, F. H. Bach, and D. E. R. Sutherland. 1991. Evidence for direct and indirect pathways in the generation of the alloimmune response against pancreatic islets. Transplantation 52:704.
43. Benichou, G., P. Takizawa, C. Oslon, M. McMillan, and E. Sercarz. 1992. Donor MHC peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175:3038.
44. Fangmann, J., R. Dalchau, and J. W. Fahre. 1993. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. Transplant. Proc. 25:183.
45. Auchincloss, J. H., R. Lee, S. Shea, J. S. Markowitz, M. J. Grusby, and L. H. Glimcher. 1993. The role of 'indirect' recognition in initiating rejection of skin grafts for major histocompatiblity complex class II-deficient mice. Proc. Natl. Acad. Sci. USA 90:3373.
46. Coulombe, M., and R. G. Gill. 1994. Tolerance induction to cultured islet allografts. II. Status of anti-donor reactivity in tolerant animals. Transplantation 57:1201.
47. Shoskes, D. A., and K. J. Wood. 1994. Indirect presentation of MHC antigens in transplantation. Immunol. Today 15:32.
48. + T cells. J. Clin. Invest. 93:1208.
49. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991.
50. Gill, R. G., M. Coulombe, and K. J. Lafferty. 1996. Pancreatic islet allograft immunity and tolerance: the two-signal hypothesis revisited. Immunol. Rev. 149: 75.